Management of a hospital outbreak of extensively drug-resistant Acinetobacter baumannii using a multimodal intervention including daily chlorhexidine baths

Journal of Hospital Infection

Volumn 93, Issue 1, 2016, Pages 29-34

  Gray, A P ^a   Allard, R ^a,b   Pare R ^b   Tannenbaum, T ^a,b   Lefebvre, B ^c   Levesque S ^c   Mulvey, M ^d   Maalouf, L ^e   Perna, S ^e   Longtin, Y ^a,e  

^a MCGILL UNIVERSITY   (Canada)

^b Montreal Public Health Department   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Acinetobacter; Antimicrobial resistance; Chlorhexidine; Healthcare associated infection; Outbreak; Screening

Indexed keywords

CHLORHEXIDINE GLUCONATE; CIPROFLOXACIN; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; VANCOMYCIN; ANTIINFECTIVE AGENT; CHLORHEXIDINE; DISINFECTANT AGENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; CAUSE OF DEATH; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; HAND WASHING; HUMAN; MALE; MASS SCREENING; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RISK FACTOR; ACINETOBACTER INFECTIONS; BACTERIAL GENE; BATH; CROSS INFECTION; DRUG EFFECTS; EPIDEMIC; INFECTION CONTROL; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; MOLECULAR TYPING; MULTIDRUG RESISTANCE; PREVENTION AND CONTROL; PROCEDURES; VERY ELDERLY;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BATHS; CHLORHEXIDINE; CROSS INFECTION; DISEASE OUTBREAKS; DISEASE TRANSMISSION, INFECTIOUS; DISINFECTANTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENES, BACTERIAL; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; MOLECULAR TYPING; POLYMERASE CHAIN REACTION;

EID: 84963507339     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2015.12.013     Document Type: Article

References (19)

1. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
2. Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006, 42:692-699.
3. Association for Professionals in Infection Control and Epidemiology Guide to the elimination of multidrug-resistant Acinetobacter baumannii transmission in healthcare settings 2010, Washington, DC.
4. Mataseje L.F., Bryce E., Roscoe D., et al. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP). J Antimicrob Chemother 2012, 67:1359-1367.
5. Tien H.C., Battad A., Bryce E.A., et al. Multi-drug resistant Acinetobacter infections in critically injured Canadian forces soldiers. BMC Infect Dis 2007, 7:95.
6. Simor A.E., Lee M., Vearncombe M., et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002, 23:261-267.
7. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
8. Marchaim D., Navon-Venezia S., Schwartz D., et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007, 45:1551-1555.
9. Clinical and Laboratory Standards Institute Performance standards for antimicrobial disk susceptibility tests; approved standard, eleventh edition 2012, CLSI, Wayne, PA.
10. Magiorakos A.-P., Srinivasan A., Carey R.B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
11. Seifert H., Strate A., Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality. Medicine 1995, 74:340-349.
12. Cisneros J.M., Rodríguez-Baño J. Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment. Clin Microbiol Infect 2002, 8:687-693.
13. Doi Y., Onuoha E.O., Adams-Haduch J.M., et al. Screening for Acinetobacter baumannii colonization by use of sponges. J Clin Microbiol 2011, 49:154-158.
14. Apisarnthanarak A., Warren D.K. Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches. Clin Infect Dis 2013, 56:1057-1059.
15. Centers for Disease Control and Prevention 2012 CRE toolkit - guidance for control of carbapenem-resistant Enterobacteriaceae (CRE) 2012, CDC, Atlanta, Available at:, [last accessed July 26, 2015]. http://www.cdc.gov/hai/organisms/cre/cre-toolkit/.
16. Chen W., Li S., Li L., Wu X., Zhang W. Effects of daily bathing with chlorhexidine and acquired infection of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus: a meta-analysis. J Thorac Dis 2013, 5:518-524.
17. Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8:751-762.
18. Boyan W, Ried J, Caton T. Skin decontamination with chlorhexidine gluconate for the control of nosocomial acinetobacter in a long term acute care hospital. Paper presented at: American Thoracic Society 2009 International Conference, San Diego, CA, USA, May 17th, 2009.
19. Biswas S., Brunel J.-M., Dubus J.-C., Reynaud-Gaubert M., Rolain J.-M. Colistin: an update on the antibiotic of the 21st century. Expert Rev Anti Infect Ther 2012, 10:917-934.